000 01553nam a22004097a 4500
008 210607s20212021 xxu||||| |||| 00| 0 eng d
022 _a1388-9842
024 _a10.1002/ejhf.2181 [doi]
040 _aOvid MEDLINE(R)
099 _a33826209
245 _aThe effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).
251 _aEuropean Journal of Heart Failure. 23(6):1052-1056, 2021 06.
252 _aEur J Heart Fail. 23(6):1052-1056, 2021 06.
252 _zEur J Heart Fail. 2021 Apr 07
253 _aEuropean journal of heart failure
260 _c2021
260 _fFY2021
265 _saheadofprint
265 _sppublish
266 _d2021-06-07
268 _aEuropean Journal of Heart Failure. 2021 Apr 07
546 _aEnglish
650 _a*Heart Failure
650 _a*Heart Failure, Systolic
650 _aCardiac Myosins
650 _aHeart Failure, Systolic/dt [Drug Therapy]
650 _aHeart Failure/dt [Drug Therapy]
650 _aHumans
650 _aStroke Volume
650 _aUrea/aa [Analogs & Derivatives]
651 _aMedStar Heart & Vascular Institute
657 _aLetter
700 _aPapolos, Alexander
790 _aClaggett B, Felker GM, Honarpour N, Kurtz CE, Legg JC, Liu J, Malik FI, McMurray JJV, Minamisawa M, Papolos AI, Solomon SD, Sorensen TB, Teerlink JR
856 _uhttps://dx.doi.org/10.1002/ejhf.2181
_zhttps://dx.doi.org/10.1002/ejhf.2181
942 _cART
_dArticle
999 _c6328
_d6328